Company Name: PhaseRx, Inc.
PhaseRx, Inc. is a preclinical biopharmaceutical company. The company is engaged in the development of intracellular enzyme replacement therapy designed to treat inherited enzyme deficiencies in the liver.
Ticker Symbol: PZRX (NASDAQ)
Company Website: http://phaserx.com
Social Media: Phaserx LinkedIn
Headquarters: Seattle, Washington